Published in J Biol Chem on February 04, 2000
Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem (2005) 1.86
GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One (2008) 1.63
Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest (2003) 1.53
The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol (2012) 1.31
The calcium-sensing receptor in bone. J Bone Miner Metab (2008) 0.92
Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int (2003) 0.90
Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors. J Cell Biochem (2005) 0.89
Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover. J Bone Miner Res (2011) 0.87
Impaired osteoblast function in GPRC6A null mice. J Bone Miner Res (2010) 0.87
Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2). Mol Endocrinol (2009) 0.85
The role of the calcium-sensing receptor in bone biology and pathophysiology. Curr Pharm Biotechnol (2009) 0.82
The hunting of the snark: the elusive calcium receptor(s). J Clin Invest (2003) 0.79
Clinical and Molecular Perspectives of Reparative Dentin Formation: Lessons Learned from Pulp-Capping Materials and the Emerging Roles of Calcium. Dent Clin North Am (2017) 0.75
Protein/amino-acid modulation of bone cell function. Bonekey Rep (2016) 0.75
Calcium Sensing Receptor Function Supports Osteoblast Survival and Acts as a Co-Factor in PTH Anabolic Actions in Bone. J Cell Biochem (2016) 0.75
Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology (2001) 1.85
MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone (2004) 1.79
Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis (1992) 1.67
Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab (2008) 1.55
G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem (1999) 1.51
Structure-function of recombinant Na/H exchanger regulatory factor (NHE-RF). J Clin Invest (1998) 1.44
Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med (1991) 1.42
Intrinsic mineralization defect in Hyp mouse osteoblasts. Am J Physiol (1998) 1.37
Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol (2009) 1.34
Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem (2004) 1.27
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int (2007) 1.18
Hemodialysis-associated subclavian vein stenosis. Kidney Int (1988) 1.18
Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine (2007) 1.17
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene (1998) 1.12
Role of the polycytin-primary cilia complex in bone development and mechanosensing. Ann N Y Acad Sci (2010) 1.07
Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J Cell Biochem (1999) 1.05
Characterization of the upstream mouse Cbfa1/Runx2 promoter. J Cell Biochem (2001) 1.05
Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we? Kidney Int (2000) 1.05
Analysis of recombinant Phex: an endopeptidase in search of a substrate. Am J Physiol Endocrinol Metab (2001) 1.03
Cloning and sequencing of human PEX from a bone cDNA library: evidence for its developmental stage-specific regulation in osteoblasts. J Bone Miner Res (1997) 1.02
Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia. J Bone Miner Res (1999) 1.01
Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem. J Clin Endocrinol Metab (2001) 1.00
Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun (2002) 0.98
An experimental canine model of osteonecrosis: characterization of the repair process. J Orthop Res (1993) 0.95
Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology (1995) 0.92
Construction of a full-length murine pro alpha 2(I) collagen cDNA by the polymerase chain reaction. J Invest Dermatol (1991) 0.92
Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice. Mol Endocrinol (2012) 0.91
A novel mouse model of podocyte depletion. Nephron Exp Nephrol (2012) 0.91
Phytoestrogens and bone. Baillieres Clin Endocrinol Metab (1998) 0.91
Staphylococcus aureus bacteremia in patients on chronic hemodialysis. Am J Kidney Dis (1985) 0.91
Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int (1996) 0.91
Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group. Kidney Int (2000) 0.90
Accumulation of 1,2-sn-diradylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline-deficient rats. J Biol Chem (1993) 0.90
Health potential of soy isoflavones for menopausal women. Public Health Nutr (1999) 0.90
Effect of asymmetric dimethylarginine on osteoblastic differentiation. Kidney Int (2001) 0.89
Effects of prolonged (1 year) choline deficiency and subsequent re-feeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liver. Carcinogenesis (1995) 0.87
Aluminum is a weak agonist for the calcium-sensing receptor. Kidney Int (1999) 0.87
Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med (1998) 0.87
Lambda light chain deposition disease in a renal allograft. Transplant Proc (2005) 0.87
Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J Immunol (1999) 0.86
Molecular to pharmacologic control of osteoblast proliferation and differentiation. J Cell Biochem (1994) 0.86
Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis. Kidney Int (1999) 0.85
Specific coupling of a cation-sensing receptor to G protein alpha-subunits in MDCK cells. Am J Physiol (1997) 0.85
Evidence of a toxic effect of ethanol on bone in rats. Alcohol Clin Exp Res (1982) 0.85
Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity. Clin Nephrol (2011) 0.85
Cytochemical bioassay of circulating concentrations of rat parathyroid hormone: application to a study of age and sex. J Bone Miner Res (1986) 0.84
Cation sensing receptors in bone: a novel paradigm for regulating bone remodeling? J Bone Miner Res (1997) 0.84
Cloning and characterization of the proximal murine Phex promoter. Endocrinology (2001) 0.84
Domains of the parathyroid hormone (PTH) receptor required for regulation by G protein-coupled receptor kinases (GRKs). Biochem Pharmacol (2001) 0.83
Identification of putative transmembrane receptor sequences homologous to the calcium-sensing G-protein-coupled receptor. Genomics (1997) 0.83
Effect of number of suckling pups and dietary calcium on bone mineral content and mechanical properties of femurs of lactating rats. Bone Miner (1988) 0.82
Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts. J Cell Physiol (1994) 0.82
Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism. Surgery (1997) 0.82
Spectrum of disease in familial focal and segmental glomerulosclerosis. Kidney Int (1999) 0.82
Identification of a rat glomerular mesangial cell mitogenic 5-HT2A receptor. Am J Physiol (1995) 0.81
Late vascular complications of the subclavian dialysis catheter. Am J Kidney Dis (1986) 0.81
Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs. Bone (1995) 0.81
A role for leukotrienes in cyclosporine nephrotoxicity. Kidney Int (2000) 0.81
Aluminum: culprit or accessory in the genesis of renal osteodystrophy. Semin Nephrol (1986) 0.81
5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation. Mol Pharmacol (1995) 0.80
Calcitonin-like immunoreactivity in rat and human pituitary glands: histochemical, in vitro, and in vivo studies. Endocrinology (1980) 0.80
Several anesthetics, but not diethyl ether, cause marked elevation of serum parathyroid hormone concentration in rats. J Bone Miner Res (1995) 0.80
Guanine nucleotide binding-protein coupled signaling pathway regulation of osteoblast-mediated bone formation. J Bone Miner Res (1996) 0.79
The ovariectomized, lactating rat as an experimental model for osteopenia: calcium metabolism and bone changes. Bone Miner (1990) 0.79
Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk. J Nutr (1993) 0.79
Thyroid and blood thyrocalcitonin concentrations and C-cell abundance in two strains of rats at different ages. Proc Soc Exp Biol Med (1976) 0.79
Complementary nature of radiotracer parathyroid imaging and intraoperative parathyroid hormone assays in the surgical management of primary hyperparathyroid disease: case report and review. Clin Nucl Med (2000) 0.78
Intensity of lactation modulates renal 1 alpha-hydroxylase and serum 1,25(OH)2D in rats. Am J Physiol (1992) 0.78
[FGF23 and the heart]. G Ital Nefrol (2014) 0.78
Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. J Immunol (2001) 0.78
Stimulation of gastrin secretion in the pig by parathyroid hormone and its inhibition by thyrocalcitonin. Endocrinology (1977) 0.78
Circulating parathyroid hormone concentrations in normal and vitamin D-deprived rat pups determined with an N-terminal-specific radioimmunoassay. Bone Miner (1986) 0.78
Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender. J Clin Endocrinol Metab (1998) 0.77
Altered regulation of parathyroid hormone secretion by calcium in pregnant and lactating rats. J Bone Miner Res (1997) 0.77
Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology (1995) 0.77
Role of platelet activating factor in kidney transplant rejection in the rat. Kidney Int (1995) 0.77
Influence of lactation and pregnancy + lactation on mechanical properties and mineral content of the rat femur. J Bone Miner Res (1987) 0.76
The effects of short-term treatment with the prostaglandin E1 (PGE1) analog misoprostol on inflammatory mediator production in murine lupus nephritis. Clin Immunol Immunopathol (1995) 0.76
Differential regulation of receptor-stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3-E1 osteoblasts. J Bone Miner Res (1996) 0.76
Oral versus intravenous calcitriol: is the route of administration really important? Curr Opin Nephrol Hypertens (1995) 0.76
X-linked hypophosphatemic rickets without "rickets". Skeletal Radiol (1991) 0.76
Hypercalcitoninemia associated with return of serum calcium concentration toward normal in chronically parathyroidectomized rats. Endocrinology (1979) 0.76
Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells. Am J Physiol (1998) 0.76
Parathyroidectomy abolishes the increase of renal 25-hydroxyvitamin D-1 alpha-hydroxylase in lactating rats. Am J Physiol (1993) 0.76
Acute lead-induced increase in serum calcium in the rat without increased secretion of calcitonin. Proc Soc Exp Biol Med (1979) 0.76
Controversy over dietary phosphorus. J Am Coll Nutr (2001) 0.75
Aluminum accumulation in patients with chronic renal disease. N Engl J Med (1991) 0.75
Salmon calcitonin reduces vertebral bone loss in glucocorticoid-treated beagles. Am J Physiol (1993) 0.75
Somatostatin inhibits and reverses hypergastrinemia induced by parathyroid hormone, calcium, and acetylcholine. Surg Forum (1977) 0.75
Sex difference in serum calcitonin level in rats as related to feeding, fasting, and age. Endocrinology (1980) 0.75
Determination of bioactive rat parathyroid hormone (PTH) concentrations in vivo and in vitro by a 2-site homologous immunoradiometric assay. Bone Miner (1994) 0.75
Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck. Clin Orthop Relat Res (1991) 0.75
Immature omental teratoma. Arch Pathol Lab Med (1987) 0.75
Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta. Am J Med Genet (1993) 0.75
Continuous arteriovenous hemodialysis: effect of dialyzer geometry. Kidney Int (1992) 0.75
Hypercalcitoninism and C-cell hyperplasia in rats with goiters produced by a low iodine diet or propylthiouracil. J Pharmacol Exp Ther (1978) 0.75